SPONSOR

University of Illinois at Chicago

Total Trials

Recruiting

Phases

Phase 2, Phase 4

Conditions studied: Kidney Transplant Symptoms Gut Microbiome Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Neoplasm Female Breast Cancer Depression Undiagnosed HIV Infection Populations That Are Reluctant to Test for HIV Long-term Undiagnosed HIV Infection Individuals With Newly-diagnosed HIV Infection

University of Illinois at Chicago is a clinical research sponsor with 19 registered studies on ClinicalTrials.gov, of which 19 are actively recruiting participants. Research covers conditions including Kidney Transplant Symptoms, Gut Microbiome, Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Neoplasm Female.

The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Illinois at Chicago

How many clinical trials has University of Illinois at Chicago sponsored?

ClinicalMetric currently tracks 19 clinical trials sponsored by University of Illinois at Chicago, of which 19 are actively recruiting participants. These trials cover conditions including Kidney Transplant Symptoms, Gut Microbiome, Breast Cancer Early Stage Breast Cancer (Stage 1-3). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Illinois at Chicago research focus on?

University of Illinois at Chicago clinical trials span Kidney Transplant Symptoms, Gut Microbiome, Breast Cancer Early Stage Breast Cancer (Stage 1-3), Breast Neoplasm Female, Breast Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Illinois at Chicago clinical trial?

To participate in a University of Illinois at Chicago trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Illinois at Chicago trials with current recruitment status updated daily.

University of Illinois at Chicago

Frequently Asked Questions — University of Illinois at Chicago

Clinical Trials by University of Illinois at Chicago

The Gut Microbiome and Serum Metabolites as a Biological Mechanism Underlying Pain in Kidney Transplantation

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life Depression

Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma

Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions

Enhancing Diabetes Care: Exposome &Amp; Sensors

Optimizing Orthodontic Appliances Efficiency With Remote Dental Monitoring and Artificial Intelligence Algorithms

The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk

Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females

Healthy ReStart Intervention to Improve Health and Functioning

Effects of Delay in Hearing Assistive Technology

A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin

My ESSENCE - A Research Study on Mindfulness for African-Americans With Type 2 Diabetes

Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease

Alternative Therapies for Improving Physical Function in Individuals With Stroke

Ischemic Preconditioning in Osteoarthritis and Back Pain